SCHEMBL24313632

SCHEMBL24313632

COc1cc(C2CC2)cc(-n2ccnc2)c1C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
CYP19A1 P11511 1/20 0.43
CGAS Q8N884 1/20 0.38
ALDH1A1 P00352 2/20 0.36
AAK1 Q2M2I8 1/20 0.35
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
MCHR1 Q99705 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
NOS2 P35228 1/20 0.34
LMNA P02545 2/20 0.33
TP53 P04637 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4D Q08499 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24313748 0.81 IDO1 (0.40) CYP11B1
SCHEMBL29588780 0.81 IDO1 (0.40) CYP11B1
SCHEMBL12174445 0.77 ERN1 (0.44) ALDH1A1LMNAPDE4BPDE4DTSHR
SCHEMBL14641983 0.72 ERN1 (0.43) ALDH1A1LMNAPDE4BPDE4DTSHR
SCHEMBL22103530 0.70 ERN1 (0.39) ALDH1A1PDE4BPDE4DTSHR
SCHEMBL1239793 0.70 ALDH1A1 (0.59) CYP11B1CYP11B2CYP19A1CGASALDH1A1
SCHEMBL1239502 0.69 CYP11B1 (0.56) CYP11B1CYP11B2CYP19A1CGASALDH1A1
SCHEMBL28090546 0.68 CYP11B1 (0.48) CYP11B1CYP11B2CYP19A1CGASALDH1A1
SCHEMBL24313743 0.67 HTR2A (0.42) ALDH1A1PDE4BPDE4DHSD17B10
SCHEMBL25188700 0.66 CD38 (0.47) CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed